vzphotos/iStock Editorial by way of Getty Pictures
- Well being Canada has authorized AbbVie’s (NYSE:ABBV) antibody-drug conjugate Elahere (mirvetuximab soravtansine) for ovarian most cancers.
- The remedy is authorized for ladies who’ve obtained one to a few different therapies.
- Extra particularly, Elahere is authorized for folate receptor-alpha (FRα) optimistic, platinum-resistant epithelial ovarian, fallopian tube, or main peritoneal
